PortfoliosLab logo
PortfoliosLab logo
Tools
Performance Analysis
Portfolio Analysis
Factor Model
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
Oculis Holding AG Warrants (OCSAW)
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Company Info

Sector

Healthcare

IPO Date

Mar 3, 2023

Highlights

Year Range

$1.60 - $11.50

Share Price Chart


Loading data...

Compare to other instruments

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Performance

Performance Chart

The chart shows the growth of an initial investment of $10,000 in Oculis Holding AG Warrants, comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.


0.00%100.00%200.00%300.00%400.00%500.00%SeptemberOctoberNovemberDecember2025February
400.01%
8.78%
OCSAW (Oculis Holding AG Warrants)
Benchmark (^GSPC)

Returns By Period

Oculis Holding AG Warrants had a return of 85.53% year-to-date (YTD) and 296.83% in the last 12 months.


OCSAW

YTD

85.53%

1M

-9.91%

6M

400.01%

1Y

296.83%

5Y*

N/A

10Y*

N/A

^GSPC (Benchmark)

YTD

4.46%

1M

2.46%

6M

9.31%

1Y

23.49%

5Y*

13.03%

10Y*

11.31%

*Annualized

Monthly Returns

The table below presents the monthly returns of OCSAW, with color gradation from worst to best to easily spot seasonal factors. Returns are adjusted for dividends.


JanFebMarAprMayJunJulAugSepOctNovDecTotal
2025109.48%85.53%
202454.00%1.73%-6.38%-8.63%0.00%-7.96%7.57%0.50%5.00%161.90%-22.73%26.82%259.33%
2023-9.43%30.37%67.59%18.27%-2.73%85.98%-15.08%-33.14%15.04%15.38%219.15%

Risk-Adjusted Performance

Risk-Adjusted Performance Rank

With an overall rank of 96, OCSAW is among the top 4% of stocks on our website when it comes to balancing risk and reward. Below is a breakdown of how it compares using common performance measures.


The Risk-Adjusted Performance Rank of OCSAW is 9696
Overall Rank
The Sharpe Ratio Rank of OCSAW is 9797
Sharpe Ratio Rank
The Sortino Ratio Rank of OCSAW is 9494
Sortino Ratio Rank
The Omega Ratio Rank of OCSAW is 9595
Omega Ratio Rank
The Calmar Ratio Rank of OCSAW is 9999
Calmar Ratio Rank
The Martin Ratio Rank of OCSAW is 9797
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

Risk-Adjusted Performance Indicators

The charts below present risk-adjusted performance metrics for Oculis Holding AG Warrants (OCSAW) and compare them to a chosen benchmark (^GSPC). These indicators evaluate an investment's returns against its associated risks.


Sharpe ratio
The chart of Sharpe ratio for OCSAW, currently valued at 2.74, compared to the broader market-2.000.002.002.741.74
The chart of Sortino ratio for OCSAW, currently valued at 3.53, compared to the broader market-4.00-2.000.002.004.006.003.532.35
The chart of Omega ratio for OCSAW, currently valued at 1.53, compared to the broader market0.501.001.502.001.531.32
The chart of Calmar ratio for OCSAW, currently valued at 6.38, compared to the broader market0.002.004.006.006.382.61
The chart of Martin ratio for OCSAW, currently valued at 19.80, compared to the broader market0.0010.0020.0030.0019.8010.66
OCSAW
^GSPC

The current Oculis Holding AG Warrants Sharpe ratio is 2.74. This value is calculated based on the past 1 year of trading data and takes into account price changes and dividends.

Use the chart below to compare the Sharpe ratio of Oculis Holding AG Warrants with the selected benchmark, providing insights into the investment's historical performance in terms of risk-adjusted returns. Go to the Sharpe ratio tool for more fine-grained control over the calculation options.


Rolling 12-month Sharpe Ratio1.002.003.004.005.00SeptemberOctoberNovemberDecember2025February
2.74
1.83
OCSAW (Oculis Holding AG Warrants)
Benchmark (^GSPC)

Dividends

Dividend History


Oculis Holding AG Warrants doesn't pay dividends

Drawdowns

Drawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.


-50.00%-40.00%-30.00%-20.00%-10.00%0.00%SeptemberOctoberNovemberDecember2025February
-11.43%
-0.07%
OCSAW (Oculis Holding AG Warrants)
Benchmark (^GSPC)

Worst Drawdowns

The table below displays the maximum drawdowns of the Oculis Holding AG Warrants. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the Oculis Holding AG Warrants was 72.36%, occurring on Jan 3, 2024. Recovery took 24 trading sessions.

The current Oculis Holding AG Warrants drawdown is 11.43%.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-72.36%Aug 28, 202366Jan 3, 202424Feb 26, 202490
-45.87%Nov 4, 20248Nov 14, 202433Jan 7, 202541
-37.72%Feb 28, 202416Apr 4, 202469Oct 7, 202485
-29.79%Mar 6, 202313Mar 24, 202313Apr 17, 202326
-29.01%May 24, 202319Jun 22, 202317Aug 9, 202336

Volatility

Volatility Chart

The current Oculis Holding AG Warrants volatility is 12.10%, representing the average percentage change in the investments's value, either up or down over the past month. The chart below shows the rolling one-month volatility.


0.00%10.00%20.00%30.00%40.00%50.00%60.00%SeptemberOctoberNovemberDecember2025February
12.10%
3.21%
OCSAW (Oculis Holding AG Warrants)
Benchmark (^GSPC)

Financials

Financial Performance

The chart below illustrates the trends in the financial health of Oculis Holding AG Warrants over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.

Annual
Quarterly

0.0

Historical P/E Ratio Chart

The chart below displays the historical trend of the price-to-earnings (P/E) ratio for Oculis Holding AG Warrants.


Loading data...

Income Statement



TTM
Revenue

Total Revenue

Cost Of Revenue

Gross Profit

Operating Expenses

Selling, General & Admin Expenses

R&D Expenses

Depreciation And Amortization

Total Operating Expenses

Income

Income Before Tax

Operating Income

EBITDA

EBIT

Earnings From Continuing Operations

Net Income

Income Tax Expense

Other Non-Operating Income (Expenses)

Extraordinary Items

Discontinued Operations

Effect Of Accounting Charges

Non Recurring

Minority Interest

Other Items

Interest Income

Interest Expense

Net Interest Income

Values in undefined except per share items
PortfoliosLab logo
Performance Analysis
Portfolio AnalysisPortfolio PerformanceStock ComparisonSharpe RatioMartin RatioTreynor RatioSortino RatioOmega RatioCalmar RatioSummers Ratio
Community
Discussions


Disclaimer

The information contained herein does not constitute investment advice and made available for educational purposes only. Prices and returns on equities are listed without consideration of fees, commissions, taxes, penalties, or interest payable due to purchasing, holding, or selling.

Copyright © 2025 PortfoliosLab